Cellular abnormalities are present in atherosclerosis Newsletter Article 17 February 2013 Pages: 2 - 3
Why are azithromycin and clarithromycin receiving attention? Newsletter Article 17 February 2013 Pages: 3 - 3
More on the relationship between H. pylori and peptic ulcers Newsletter Article 17 February 2013 Pages: 4 - 4
Intermittent intrathecal drug administration associated with meningitis Newsletter Article 17 February 2013 Pages: 4 - 4
Pharmacotherapy for jet-lag - still a long way to go Newsletter Article 17 February 2013 Pages: 5 - 5
Lancet editorial criticises delay over Chinese malaria remedy Newsletter Article 17 February 2013 Pages: 7 - 8
No adverse effects with Genentech’s novel cystic fibrosis treatment Newsletter Article 17 February 2013 Pages: 10 - 10
Gemfibrozil reduces the progression of arterial wall changes Newsletter Article 17 February 2013 Pages: 12 - 12
A potential new database using linked prescription and patient data Newsletter Article 17 February 2013 Pages: 12 - 12
No benefit with prolonged antineoplastic therapy in SCLC Newsletter Article 17 February 2013 Pages: 12 - 12
Anthracyclines should be a major component of adjuvant breast cancer therapy List Hollingshead Newsletter Article 17 February 2013 Pages: 13 - 15
Beta blockers improve prognosis of dilated cardiomyopathy Newsletter Article 17 February 2013 Pages: 16 - 16
Nizatidine heals oesophagitis in gastro-oesophageal disease Newsletter Article 17 February 2013 Pages: 16 - 16
Successful treatment of Wegener granulomatosis is not without a price Newsletter Article 17 February 2013 Pages: 17 - 17
G-CSF-mobilised cells aid neutrophil and platelet recovery Newsletter Article 17 February 2013 Pages: 18 - 18
Nadolol is safe and effective in children with supraventricular tachycardia Newsletter Article 17 February 2013 Pages: 19 - 19
ACE inhibitor warning to be emphasised at FDA request Newsletter Article 17 February 2013 Pages: 20 - 21
Accelerated alteplase regimens - more studies warranted Newsletter Article 17 February 2013 Pages: 21 - 21
Immune activation markers predict zidovudine efficacy Newsletter Article 17 February 2013 Pages: 21 - 22
More information is needed on the actions of acetylcysteine Newsletter Article 17 February 2013 Pages: 22 - 22